Biomni
Biomni, released on July 9, 2026, by the Stanford University SNAP Lab, is a bio-specialized general-purpose AI agent system that autonomously plans and executes complex and extensive life science research workflows. This tool operates in a manner similar to an experienced bioinformatician skillfully navigating various biological databases and local analysis tools to design optimal pipelines. Biomni leverages the inference capabilities of large language models (LLMs) and retrieval-augmented planning.
Biomni, released on July 9, 2026, by the Stanford University SNAP Lab, is a bio-specialized general-purpose AI agent system that autonomously plans and executes complex and extensive life science research workflows. This tool operates in a manner similar to an experienced bioinformatician skillfully navigating various biological databases and local analysis tools to design optimal pipelines. Biomni integrates the inference capabilities of large language models (LLMs), retrieval-augmented planning, and code execution in a real-world sandbox environment to formulate hypotheses based on researcher queries and automatically generate and validate the necessary code.
Traditional bioinformatic analysis methods have been cumbersome, requiring researchers to manually search dozens of different web databases, such as NCBI and ChEMBL, or to intricately combine various specialized analysis software packages based on R and Python. To overcome the limitations of this fragmented research environment, Biomni seamlessly integrates over 150 bio-specialized analysis tools, 59 curated databases, and 105+ software packages into a single intelligent agent platform. This is akin to a conductor organically connecting numerous individual research tools, going beyond simply listing API calls to understand complex data flows, autonomously correct errors through multi-step reasoning, and derive optimal analysis results.
Life science researchers can use Biomni to drastically shorten the entire process, from gene editing design to the discovery of new drug candidates. For example, a researcher performing a CRISPR knock-out screen analysis to identify immune checkpoint modulators can set MAGeCK parameters (alpha_cutoff=0.05) with natural language commands and automatically extract 32 significant regulatory genes from the data lake. Furthermore, by inputting single-cell RNA sequencing (scRNA-seq) expression matrix data, the system can complete everything from preprocessing with cell filtering parameters (min_genes=200) to automated cell annotation using the CellMarker database within 1-2 seconds, providing hypothesis validation and visualization reports simultaneously.
💻 System Requirements
0 (API 기반 LLM 사용 시 VRAM 불필요, 로컬 모델 활용 시 NVIDIA GPU 8GB+ 권장)
최소 30GB 이상의 디스크 공간 (데이터레이크 11GB 및 환경 설치용)
⚡ Installation
4-1. Quick Start
conda activate biomni_e1 pip install biomni --upgrade
4-2. 상세 설치
1. 깃허브 저장소 복제 및 환경 설정 경로 이동git clone https://github.com/snap-stanford/Biomni.git cd Biomni/biomni_env
2. 콘다 환경 설치 방식 선택 (기본 설치) 기본 에이전트 테스트 환경 구축conda env create -f environment.yml
(전체 설치) 150+ 분석 툴이 내장된 풀 E1 환경 설치 (10시간 이상 소요, 30GB+ 공간 필요)bash setup.sh
3. 환경 활성화 및 공식 pip 패키지 설치conda activate biomni_e1 pip install biomni --upgrade
4. 프로젝트 디렉토리에 API 키 설정 (.env 파일 생성 및 키 입력) cp .env.example .env🧬 Bio Use Cases
🔬 CRISPR Screen Design and Target Gene Selection
The Biomni agent analyzes immune checkpoint genes from 59 biological databases to establish a CRISPR knock-out screen protocol, sets MAGeCK parameters (alpha_cutoff=0.05), and ultimately selects and recommends 32 optimal guide RNA (gRNA) candidates that can inhibit T-cell depletion.
💊 Compound Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Prediction and Hypothesis Validation
By inputting a SMILES string (CC(C)CC1=CC=C(C=C1)C(C)C(=O)O), the system operates RDKit and the SwissADME API in conjunction, calculates the partition coefficient (LogP=3.5) and cardiotoxicity index (hERG blocking activity IC50 > 10uM), and automatically generates a report outlining the hypothesis regarding the bioavailability of the drug candidate.
🧬 Automated Annotation of Single-Cell RNA Sequencing (scRNA-seq) Data and Analysis of the Immune Microenvironment
Using Scanpy package parameters (min_genes=200, min_cells=3), the system preprocesses the gene expression matrix of tumor immune microenvironment cells and automatically annotates the cell type of each cluster (e.g., T cells, macrophages) based on the CellMarker database within 1-2 seconds, generating a report on the heterogeneity within the tumor.
FAQ
What is Biomni?
Biomni, released on July 9, 2026, by the Stanford University SNAP Lab, is a bio-specialized general-purpose AI agent system that autonomously plans and executes complex and extensive life science research workflows. This tool operates in a manner similar to an experienced bioinformatician skillfully navigating various biological databases and local analysis tools to design optimal pipelines. Biomni integrates the inference capabilities of large language models (LLMs), retrieval-augmented planning, and code execution in a real-world sandbox environment to formulate hypotheses based on researcher queries and automatically generate and validate the necessary code. Traditional bioinformatic analysis methods have been cumbersome, requiring researchers to manually search dozens of different web databases, such as NCBI and ChEMBL, or to intricately combine various specialized analysis software packages based on R and Python. To overcome the limitations of this fragmented research environment, Biomni seamlessly integrates over 150 bio-specialized analysis tools, 59 curated databases, and 105+ software packages into a single intelligent agent platform. This is akin to a conductor organically connecting numerous individual research tools, going beyond simply listing API calls to understand complex data flows, autonomously correct errors through multi-step reasoning, and derive optimal analysis results. Life science researchers can use Biomni to drastically shorten the entire process, from gene editing design to the discovery of new drug candidates. For example, a researcher performing a CRISPR knock-out screen analysis to identify immune checkpoint modulators can set MAGeCK parameters (alphacutoff=0.05) with natural language commands and automatically extract 32 significant regulatory genes from the data lake. Furthermore, by inputting single-cell RNA sequencing (scRNA-seq) expression matrix data, the system can complete everything from preprocessing with cell filtering parameters (mingenes=200) to automated cell annotation using the CellMarker database within 1-2 seconds, providing hypothesis validation and visualization reports simultaneously.
When should I use Biomni?
Biomni, released on July 9, 2026, by the Stanford University SNAP Lab, is a bio-specialized general-purpose AI agent system that autonomously plans and executes complex and extensive life science research workflows. This tool operates in a manner similar to an experienced bioinformatician skillfully navigating various biological databases and local analysis tools to design optimal pipelines. Biomni leverages the inference capabilities of large language models (LLMs) and retrieval-augmented planning.
What is a biomedical use case for Biomni?
🔬 CRISPR Screen Design and Target Gene Selection: The Biomni agent analyzes immune checkpoint genes from 59 biological databases to establish a CRISPR knock-out screen protocol, sets MAGeCK parameters (alpha_cutoff=0.05), and ultimately selects and recommends 32 optimal guide RNA (gRNA) candidates that can inhibit T-cell depletion.
📝 Update Notes
No update notes yet.
🧪 Related Code of Life
No related Code of Life posts yet.